FDA.reportPublic FDA data

These highlights do not include all the information needed to use DELFLEX

Manufacturer
Fresenius Medical Care de Mexico, S.A. de C.V. | Fresenius Medical Care Renal Therapies Group, LLC
Effective date
2026-07-27
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
11
Source
daily-update
Hydrated at
2026-07-29 05:10:28

Label at a glance#

ProductDelflex
Active ingredientSODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, DEXTROSE MONOHYDRATE
Label structure21 sections

Indications and uses

DELFLEX® is indicated in the treatment of chronic kidney failure patients being maintained on peritoneal dialysis

Dosage and administration

DELFLEX® is intended for intraperitoneal administration only. Not for intravenous or intra-arterial administration. The mode of therapy, frequency of treatment, formulation, exchange volume, duration of dwell, and length of dialysis should be selected by the physician responsible for the treatment of the individual patient. Utilize the peritoneal dialysis solution with lowest level of osmolarity consistent with th...

Storage and handling

DELFLEX peritoneal dialysis solutions with attached stay•safe exchange set are available in the sizes and formulations shown in Table 1 [Dosage Forms and Strengths]. (3) DELFLEX peritoneal dialysis solutions are delivered in transparent, single-dose flexible bags. The solution is clear with color being slightly yellow to colorless. Table 3. DELFLEX peritoneal dialysis with attached stay•safe exchange set NDC desig...

Label contents#

Full prescribing information#

1. INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

DELFLEX® is indicated in the treatment of chronic kidney failure patients being maintained on peritoneal dialysis

2. DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

2.1 Basic Dosing Information

SPL UNCLASSIFIED SECTION

DELFLEX® is intended for intraperitoneal administration only. Not for intravenous or intra-arterial administration.

The mode of therapy, frequency of treatment, formulation, exchange volume, duration of dwell, and length of dialysis should be selected by the physician responsible for the treatment of the individual patient.

Utilize the peritoneal dialysis solution with lowest level of osmolarity consistent with the fluid removal requirements for that exchange.

Do not store solutions containing additives.

2.2 Administration Instructions

SPL UNCLASSIFIED SECTION

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

Do not heat in a microwave oven.

Get Ready

  1. Clean work surface and gather supplies:
    • Masks (enough for everyone in the room).
    • Warmed DELFLEX peritoneal dialysis bag with attached stay•safe exchange set.
    • stay•safe organizer, a stand-alone item provided separately.
    • Povidone iodine prefilled stay•safe cap, a stand-alone item provided separately.
    • IV Pole (optional).
    • Prescribed medication(s), if ordered by your healthcare provider.
  1. After removing the overwrap, check your DELFLEX solution bag(s) for (strength, clarity, amount, leaks, and expiration date). Do not use DELFLEX solution if leaks are found, the solution bag is damaged, and/or the solution is cloudy or discolored, or the product is expired. Color may vary from clear to slightly yellow but does not affect efficacy and may be used.

  1. Prepare supplies:
    1. Retrieve stay•safe catheter extension set and ensure clamp is closed.
    2. Tear the overwrap from the slit edge down the length of the inner bag to open.
    3. Wipe away any moisture from the solution bags. Some opacity may be observed in the plastic of the bag and/or tubing and is due to moisture absorption during the sterilization process. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
    4. Visually check that the solution bag tubing is free from kinks. If kinks are present, straighten tubing to allow the solution to flow freely.
      Note: Retain DELFLEX peritoneal dialysis bag sample for manufacturer evaluation and notify your healthcare provider if any of the above defects are found.
    5. Put on mask. Wash your hands per facility protocol.
    6. Position the stay•safe organizer at the edge of your clean work surface or with the stay•safe holder on the IV pole.
 
  1. Remove color-coded cover:
    1. Turn the blue dial as directed by the arrow in the color-coded cover.
    2. Remove the color-coded cover from the stay•safe DISC. The blue dial will be in Position 1(●) DRAIN.
FigureFigure
 
  1. Prepare organizer and solution bag:
    1. Place the stay•safe DISC and tubing into the organizer and tubing channels on the organizer.
    2. If you will be adding medication(s):
      1. Clean hands (as per facility's protocol).
      2. Clean the medication port as instructed by your healthcare provider.
      3. Add the medicine(s).
      4. Turn the bag upside down several times to mix the medicine(s).
    3. Hang the DELFLEX peritoneal dialysis solution bag on the IV pole and place the drain bag with the clear side up on the floor.
    4. Break cone of the administration port.
FigureFigure
 
  1. Remove new stay•safe cap from its package and place stay•safe cap into the left notch of the organizer.
FigureFigure
  1. Place stay•safe catheter extension set into organizer.
    1. Clean hands (as per facility's protocol).
    2. Place stay•safe catheter extension set into the right notch of the organizer.
    3. Ensure clamp of stay•safe catheter set is closed.
FigureFigure
 
  1. Remove protective cap from stay•safe DISC and set aside.
FigureFigure
 
  1. Connect stay•safe catheter extension set to the stay•safe DISC.
    1. Unscrew stay•safe catheter extension set from its cap.
    2. Immediately connect the stay•safe catheter extension to the stay•safe DISC.
    3. Open the white clamp of stay•safe catheter extension set and start DRAIN.
    4. Place discarded protective cap from stay•safe DISC onto the used stay•safe cap in the stay•safe organizer and discard.
FigureFigure
 
  1. When DRAIN is complete:
    1. Turn blue dial to Position 2(●●), FLUSH for about 5 seconds.
    2. Make sure the line between solution bag and stay•safe DISC is fully primed.
FigureFigure
 
  1. When FLUSH is complete:
    1. Turn blue dial to Position 3(⚪◐●), FILL to begin the fill of solution to your abdomen. Flow rate can be adjusted from slow (⚪) to moderate (◐) to fast (●).
FigureFigure
 
  1. When FILL is complete:
    1. Turn blue dial as far as possible in Position 4(●●●●), PIN/CLOSE until you feel and/or hear a “click”.
    2. The stay•safe PIN located in the stay•safe DISC will automatically be released into the end of the stay•safe catheter extension set.
FigureFigure
 
  1. When PIN/CLOSE is complete:
    1. Close the clamp of the stay•safe catheter extension set.
    2. Using aseptic technique, mask then wash hands as instructed by your healthcare provider.
    3. Unscrew protective cover from the new stay•safe cap and set aside.
FigureFigure
 
  1. Disconnect from stay•safe DISC:
    1. Unscrew the stay•safe catheter extension set from the stay•safe DISC.
    2. Immediately attach the stay•safe catheter extension set with a PIN to the new stay•safe cap.
    3. Remove capped catheter extension set from organizer and secure to your abdomen.
FigureFigure
 
  1. Complete treatment:
    1. Place protective cover from the new stay•safe cap on the stay•safe DISC connector to prevent drips.
    2. Weigh drain bag (as per facility's protocol).
    3. Record exchange results on treatment log.
    4. If an effluent sample is required:
      1. Use aseptic technique and facility protocols throughout collection.
      2. Scrub the drain bag's sample port hub with friction and an Isopropyl Alcohol 70% swab/prep pad for 15 seconds, and allow to dry for 30 seconds more.
      3. Withdraw the effluent sample directly from the sample port hub with a needle and a syringe.
    5. Discard the used tubing and solution (as per facility's protocol).
    6. Throw away the fluid and used exchange set as instructed by your healthcare provider. In case of cloudiness, save the fluid and the used exchange set and immediately contact your healthcare provider.

2.3 Compatible Medications

SPL UNCLASSIFIED SECTION

Compatible medications can be added via the medication port [ see Dosage and Administration ( 2.2) ]. The following medications have demonstrated stability with DELFLEX solutions: cefazolin, ceftazidime, gentamicin, and vancomycin [ see Clinical Pharmacology ( 12.3) ].

3. Dosage Forms and Strengths

DOSAGE FORMS & STRENGTHS SECTION

DELFLEX peritoneal dialysis solutions are available in transparent single-dose flexible bags. The solution is clear with color being slightly yellow to colorless. All DELFLEX peritoneal dialysis solutions have overfills declared on the bag label. The flexible bag has the capacity for drainage in excess of their stated fill volume for ultrafiltration from the patient.

DELFLEX peritoneal dialysis solutions with an attached stay•safe exchange set are available in the sizes and formulations shown in Table 1.

Table 1. DELFLEX peritoneal dialysis solution with attached stay•safe exchange set sizes and formulations
2L2.5L3L
DELFLEX Low Magnesium,
Low Calcium with 1.5% Dextrose 		XXX
DELFLEX Low Magnesium,
Low Calcium with 2.5% Dextrose 		XXX
DELFLEX Low Magnesium,
Low Calcium with 4.25% Dextrose 		XXX

4. Contraindications

CONTRAINDICATIONS SECTION

None.

5. Warnings and Precautions

WARNINGS AND PRECAUTIONS SECTION

5.1 Electrolyte, Fluid and Nutrition Imbalances

SPL UNCLASSIFIED SECTION

Peritoneal dialysis may affect a patient's protein, water-soluble vitamin, potassium, sodium, chloride, bicarbonate, and magnesium levels and volume status. Monitor electrolytes and blood chemistry periodically and take appropriate clinical action.

Potassium is omitted from DELFLEX solutions because dialysis may be performed to correct hyperkalemia. In situations where there is a normal serum potassium level or hypokalemia, the addition of potassium chloride (up to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia.

To avoid the risk of severe dehydration or hypovolemia and to minimize the loss of protein, it is advisable to select the peritoneal dialysis solution with lowest level of osmolarity consistent with the fluid removal requirements for that exchange.

Significant loss of protein, amino acids and water-soluble vitamins may occur during peritoneal dialysis. Replacement therapy should be provided as necessary.

5.2 Peritonitis and Encapsulating Peritoneal Sclerosis

SPL UNCLASSIFIED SECTION

Infectious and aseptic peritonitis has been associated with peritoneal dialysis therapy. Following DELFLEX use, inspect the drained fluid for the presence of fibrin or cloudiness, which may indicate the presence of peritonitis. Improper clamping or priming sequence may result in infusion of air into the peritoneal cavity, which may result in abdominal pain and/or peritonitis. If peritonitis occurs, treat with appropriate therapy.

Encapsulating peritoneal sclerosis (EPS), sometimes fatal, is a complication of peritoneal dialysis therapy.

5.2 Lactic Acidosis

SPL UNCLASSIFIED SECTION

Monitor patients with conditions known to increase the risk of lactic acidosis [e.g., severe hypotension or sepsis that can be associated with acute kidney failure, inborn errors of metabolism, treatment with drugs such as nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)] for lactic acidosis before the start of treatment and during treatment with DELFLEX.

Solutions containing the lactate ion should be used with great care in patients with metabolic or respiratory alkalosis. Lactate should be administered with great care in those conditions in which there is an increased level or an impaired utilization of this ion, such as severe hepatic insufficiency.

5.4 Over Infusion

SPL UNCLASSIFIED SECTION

Over infusion of peritoneal dialysis solution volume into the peritoneal cavity may be characterized by abdominal distention, feeling of fullness and/or shortness of breath. Drain the peritoneal dialysis solution from the peritoneal cavity to treat over infusion.

6. ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Solution related adverse reactions may include peritonitis, catheter site infection, electrolyte and fluid imbalances, hypovolemia, hypervolemia, hypertension, hypotension, disequilibrium syndrome, muscle cramping, abdominal pain, abdominal distension, and abdominal discomfort.

8. USE IN SPECIFIC POPULATIONS

USE IN SPECIFIC POPULATIONS SECTION

8.1 Pregnancy

PREGNANCY SECTION

SPL UNCLASSIFIED SECTION

Risk Summary

DELFLEX solutions consist of electrolytes, lactate, and bicarbonate at physiological levels, and glucose to facilitate ultrafiltration. While there are no adequate and well controlled studies in pregnant women, appropriate administration of DELFLEX with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to cause fetal harm. Animal reproduction studies have not been conducted with DELFLEX.

The estimated background risk of major birth defects and miscarriage for the indicated population are unknown. All pregnancies have a background risk of birth defect, loss or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively.

8.2 Lactation

LACTATION SECTION

SPL UNCLASSIFIED SECTION

Risk Summary

The components of DELFLEX solutions are excreted in human milk. Appropriate administration of DELFEX solutions with monitoring of fluid, electrolyte, acid-base and glucose balance, is not expected to harm a nursing infant.

8.4 Pediatric Use

PEDIATRIC USE SECTION

Safety and effectiveness in pediatric patients have not been established.

11. DESCRIPTION

DESCRIPTION SECTION

The DELFLEX® peritoneal dialysis solutions (low magnesium/low calcium) are sterile, non-pyrogenic formulations of dextrose and electrolytes in water for injection, USP, for use in peritoneal dialysis. These solutions do not contain antimicrobial agents or additional buffers. The stay•safe exchange set utilizes an easy to use dial designed to eliminate the use of clamps and to prevent touch contamination of internal connection components. Composition, calculated osmolarity, pH, and ionic concentrations are shown in Table 2.

Table 2. Composition, calculated osmolarity, pH and ionic concentration
Composition/100mLTotal Osmolarity (mOsmoL/L) (calc)pH (5.0 - 6.0)Ionic Concentration (mEq/L)
Dextrose Hydrous, USP (C 6H 12O 6•H 2O) Sodium Chloride, USP (NaCl)Sodium Lactate (C3H5NaO3)Calcium Chloride, USP (CaCl 2•2H 2O) Magnesium Chloride, USP (MgCl 2•6H 2O) SodiumCalciumMagnesiumChlorideLactate
DELFLEX Low Magnesium, Low Calcium with 1.5% Dextrose1.5 g538 mg448 mg18.4 mg5.08 mg3445.51322.50.59540
DELFLEX Low Magnesium, Low Calcium with 2.5% Dextrose2.5 g538 mg448 mg18.4 mg5.08 mg3945.51322.50.59540
DELFLEX Low Magnesium, Low Calcium with 4.25% Dextrose4.25g538 mg448 mg18.4 mg5.08 mg4835.51322.50.59540

Dextrose, USP, is chemically designated D-glucose monohydrate (C 6H 12O 6•H 2O) a hexose sugar freely soluble in water. The structural formula is shown here:

Figure
Figure

Calcium chloride, USP, is chemically designated calcium chloride dihydrate (CaCl 2•2H 2O) white fragments or granules freely soluble in water.

Magnesium chloride, USP, is chemically designated magnesium chloride hexahydrate (MgCl 2•6H 2O) colorless flakes or crystals very soluble in water.

Sodium lactate solution, USP, is chemically designated (CH 3CH(OH)COONa), a 60% aqueous solution miscible in water.

Sodium chloride, USP, is chemically designated (NaCl), a white, crystalline compound freely soluble in water.

Water for injection, USP, is chemically designated (H 2O).

Hydrochloric Acid or Sodium Hydroxide may be added for pH adjustment. pH is 5.5 ± 0.5.

Exposure to temperatures above 25°C (77°F) during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period. Since the inner bag is compounded from a specific polyvinyl chloride, water may permeate from the inner bag into the overwrap in quantities insufficient to affect the solution significantly. Solutions in contact with the plastic inner bag can cause certain chemical components of the bag to leach out in very small amounts; however, the safety of the plastic formulation is supported by biological tests for plastic containers.

12. CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

12.1 Mechanism of Action

MECHANISM OF ACTION SECTION

DELFLEX peritoneal dialysis solutions are hypertonic peritoneal dialysis solutions containing dextrose, a monosaccharide, as the primary osmotic agent. An osmotic gradient must be created between the peritoneal membrane and the dialysis solution in order for ultrafiltration to occur. The hypertonic concentration of glucose in DELFLEX solutions exert an osmotic pressure across the peritoneal membrane resulting in transcapillary ultrafiltration. Like other peritoneal dialysis solutions, DELFLEX solutions contain electrolytes to facilitate the correction of acid-base and electrolyte abnormalities. DELFLEX solutions contain a buffer, lactate, to help normalize acid-base abnormalities.

12.3 Pharmacokinetics

PHARMACOKINETICS SECTION

SPL UNCLASSIFIED SECTION

Absorption

Glucose can be rapidly absorbed from the peritoneal cavity by diffusion and appears quickly in the circulation due to the high glucose concentration gradient between DELFLEX solutions compared to blood capillary glucose level. Absorption per unit time will be the highest at the start of an exchange and decreases over time. The rate of glucose absorption will be dependent upon the transport characteristics of the patient's peritoneal membrane as determined by a peritoneal equilibration test (PET). Glucose absorption will also depend upon the concentration of glucose used for the exchange and the length of the dwell. Transport of other molecules will be dependent upon the molecular size of the solute, the concentration gradient, and the effective peritoneal surface area as determined by the PET.

SPL UNCLASSIFIED SECTION

Metabolism and Elimination

Glucose is metabolized by normal cellular pathways (i.e., glycolysis). Metabolism of lactate occurs in the liver and results in the generation of the bicarbonate. Glucose not absorbed during PD exchange procedure is removed by drainage of the PD solution from the peritoneal cavity.

SPL UNCLASSIFIED SECTION

Drug Interaction Studies

SPL UNCLASSIFIED SECTION

Antibiotics

No formal clinical drug interaction studies have been performed. In vitro studies of the following medications have demonstrated stability with DELFLEX solutions: cefazolin, ceftazidime, gentamicin, and vancomycin.

13. NONCLINICAL TOXICOLOGY

NONCLINICAL TOXICOLOGY SECTION

13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

Long term animal studies with DELFLEX peritoneal dialysis solutions have not been performed to evaluate the carcinogenic potential, mutagenic potential or effect on fertility.

16. HOW SUPPLIED/STORAGE AND HANDLING

HOW SUPPLIED SECTION

DELFLEX peritoneal dialysis solutions with attached stay•safe exchange set are available in the sizes and formulations shown in Table 1[Dosage Forms and Strengths]. (3) DELFLEX peritoneal dialysis solutions are delivered in transparent, single-dose flexible bags. The solution is clear with color being slightly yellow to colorless.

Table 3. DELFLEX peritoneal dialysis with attached stay•safe exchange set NDC designations
Magnesium (Mg); Calcium (Ca)
Unit Volume2L2.5L3L
Number of units per carton554
Low Mg/Low Ca 1.5% Dextrose46163-206-9246163-206-9446163-206-95
Low Mg/Low Ca 2.5% Dextrose46163-209-9246163-209-9446163-209-95
Low Mg/Low Ca 4.25% Dextrose46163-212-9246163-212-9446163-212-95

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (between 59°F and 86°F). See USP Controlled Room Temperature. Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized.

Keep DELFLEX and all medicines out of the reach of children.

17. PATIENT COUNSELING INFORMATION

INFORMATION FOR PATIENTS SECTION

Aseptic technique must be used throughout the procedure and at its termination in order to reduce the possibility of infection.

The solution bag should remain in the carton and the overwrap intact until time of use.

Use only after checking for strength, clarity, amount, leaks, and expiration date.

Advise patients that DELFLEX peritoneal dialysis solution should not be heated in a microwave oven.

Disconnect from stay•safe DISC only when the blue dial is in position 4(●●●●) to ensure the fluid path of the stay•safe catheter extension set is sealed.

Care should be taken to ensure that there is not any leakage around the catheter, since if not controlled, the leakage can create edema from subcutaneous infiltration of the dialysis solution. The leakage will also create an inaccurate fluid balance measurement. If any leakage is identified, do not proceed with infusion and notify your physician.

FigureFigure

Fresenius Medical Care North America
920 Winter Street
Waltham, MA 02451
1-800-323-5188
Made in Mexico

© 2020 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, triangle logo, stay•safe, DELFLEX, are trademarks of Fresenius Medical Care Holding, Inc. or its affiliated companies.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 1.5% Dextrose 3000 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
1.5% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-30321

NDC 46163-206-95

3000 mL
(Approx. 60 mL excess)

Principal Display Panel – 1.5% Dextrose 3000 mL Bag LabelPrincipal Display Panel – 1.5% Dextrose 3000 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 2.5% Dextrose 3000 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
2.5% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-30322

NDC 46163-209-95

3000 mL
(Approx. 60 mL excess)

Principal Display Panel – 2.5% Dextrose 3000 mL Bag LabelPrincipal Display Panel – 2.5% Dextrose 3000 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 4.25% Dextrose 3000 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
4.25% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-30324

NDC 46163-212-95

3000 mL
(Approx. 60 mL excess)

Principal Display Panel – 4.25% Dextrose 3000 mL Bag LabelPrincipal Display Panel – 4.25% Dextrose 3000 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 1.5% Dextrose 2000 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
1.5% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-20221

NDC 46163-206-92

2000 mL
(Approx. 40 mL excess)

Principal Display Panel – 1.5% Dextrose 2000 mL Bag LabelPrincipal Display Panel – 1.5% Dextrose 2000 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 1.5% Dextrose 2500 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
1.5% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-25321

NDC 46163-206-94

2500 mL
(Approx. 50 mL excess)

Principal Display Panel – 1.5% Dextrose 2500 mL Bag LabelPrincipal Display Panel – 1.5% Dextrose 2500 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 2.5% Dextrose 2000 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
2.5% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-20222

NDC 46163-209-92

2000 mL
(Approx. 40 mL excess)

Principal Display Panel – 2.5% Dextrose 2000 mL Bag LabelPrincipal Display Panel – 2.5% Dextrose 2000 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 2.5% Dextrose 2500 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
2.5% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-25322

NDC 46163-209-94

2500 mL
(Approx. 50 mL excess)

Principal Display Panel – 2.5% Dextrose 2500 mL Bag LabelPrincipal Display Panel – 2.5% Dextrose 2500 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 4.25% Dextrose 2000 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
4.25% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-20224

NDC 46163-212-92

2000 mL
(Approx. 40 mL excess)

Principal Display Panel – 4.25% Dextrose 2000 mL Bag LabelPrincipal Display Panel – 4.25% Dextrose 2000 mL Bag Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display Panel – 4.25% Dextrose 2500 mL Bag Label

DELFLEX®

PERITONEAL DIALYSIS SOLUTION
With
4.25% DEXTROSE

LOW MAGNESIUM / LOW CALCIUM

and attached

stay•safe®Exchange Set

CAT. NO. 054-25324

NDC 46163-212-94

2500 mL
(Approx. 50 mL excess)

Principal Display Panel – 4.25% Dextrose 2500 mL Bag LabelPrincipal Display Panel – 4.25% Dextrose 2500 mL Bag Label

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6e3c022f-0786-43f1-8857-edff89d5153fProduct name120260309
95250459-30e4-45c1-b08a-993044f49109Product name220250805
bee4fa8d-8d82-423a-a0b5-40a89dd13a99Product name120250618
e0d2eb29-08bd-4bba-90d1-c91c68a38767Product name420250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
bed0530e-f939-4541-956b-6928a2f6404fProduct name120241008
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name620240814
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
334fe8d2-68fb-4331-a576-420e302ec069Product name720240320
efd58652-cb8f-4018-91ca-4b0eb2ff729fProduct name720240226
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
2641ccb3-721d-4fbf-9f2f-ca2f18157a62Product name320210309
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
e92765c1-be81-432a-b909-1b10777ec378Product name120190208
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
cefa60e2-a5b5-493e-9c54-24735b7dc509Product name220171212
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
e7e58cd3-cacb-49df-8d34-1ee335614abbProduct name120150609
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
0441a8f5-3835-497c-aedd-bc78cba56b2aProduct name120150317
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
46163-20946163-209-92, 46163-209-94, 46163-209-95
46163-21246163-212-95, 46163-212-92, 46163-212-94
46163-20646163-206-92, 46163-206-94, 46163-206-95

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Name, UNII, Kind table
NameUNIIKind
SODIUM CHLORIDE451W47IQ8XACTIB
SODIUM LACTATETU7HW0W0QTACTIB
CALCIUM CHLORIDEM4I0D6VV5MACTIB
MAGNESIUM CHLORIDE02F3473H9OACTIB
DEXTROSE MONOHYDRATELX22YL083GACTIB
WATER059QF0KO0RIACT
DEXTROSE MONOHYDRATELX22YL083GACTIB
SODIUM CHLORIDE451W47IQ8XACTIB
SODIUM LACTATETU7HW0W0QTACTIB
CALCIUM CHLORIDEM4I0D6VV5MACTIB
MAGNESIUM CHLORIDE02F3473H9OACTIB
WATER059QF0KO0RIACT
DEXTROSE MONOHYDRATELX22YL083GACTIB
SODIUM CHLORIDE451W47IQ8XACTIB
SODIUM LACTATETU7HW0W0QTACTIB
CALCIUM CHLORIDEM4I0D6VV5MACTIB
MAGNESIUM CHLORIDE02F3473H9OACTIB
WATER059QF0KO0RIACT

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
102025-11-23full-release2026-05-31 21:47:07

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19
N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19
N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINERCALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
N020171-001AT
N020171-002AT
N020171-003AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1984e616aacf4f…
2026-09-14 22:38:342026-08N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1984e616aacf4f…
2026-09-14 22:38:342026-08N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1984e616aacf4f…
2026-08-18 06:07:402026-07N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19caaa826d4ba7…
2026-08-18 06:07:402026-07N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19caaa826d4ba7…
2026-08-18 06:07:402026-07N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1931067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1931067a03dcf5…
2025-08-23 18:47 UTC2025-08N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-196a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-196a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-196a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1903ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1903ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-192680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-192680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-192680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-195bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-195bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-195bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19d06236e962d9…
2024-10-29 15:01 UTC2024-10N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19d06236e962d9…
2024-10-29 15:01 UTC2024-10N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1979d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020171-002DELFLEX W/ DEXTROSE 2.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;2.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1979d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020171-003DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;4.25GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-1979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020171-001DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER18.4MG/100ML;1.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100MLSOLUTION / INTRAPERITONEALATRLD, RS1992-08-19301d65b070ca…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08N020171-001AT184e616aacf4f…
2026-09-14 22:38:342026-08N020171-002AT184e616aacf4f…
2026-09-14 22:38:342026-08N020171-003AT184e616aacf4f…
2026-08-18 06:07:402026-07N020171-001AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N020171-002AT1caaa826d4ba7…
2026-08-18 06:07:402026-07N020171-003AT1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020171-001AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020171-002AT1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020171-003AT1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020171-001AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020171-002AT131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020171-003AT131067a03dcf5…
2025-08-23 18:47 UTC2025-08N020171-001AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020171-002AT16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020171-003AT16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020171-001AT1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020171-002AT1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020171-003AT1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020171-001AT1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020171-002AT1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020171-003AT1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020171-001AT103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020171-002AT103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020171-003AT103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020171-001AT12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020171-002AT12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020171-003AT12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020171-001AT15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020171-002AT15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020171-003AT15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020171-001AT1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020171-002AT1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020171-003AT1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020171-001AT1d06236e962d9…
2024-10-29 15:01 UTC2024-10N020171-002AT1d06236e962d9…
2024-10-29 15:01 UTC2024-10N020171-003AT1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020171-001AT179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020171-002AT179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020171-003AT179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020171-001AT1301d65b070ca…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DelflexDEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDEFresenius Medical Care de Mexico, S.A. de C.V.a98facd6-9daa-4d37-8209-63a0599dbfaa2026-07-27Warnings, Adverse reactionsExact identifier
ndc (package): 46163-209-94
ndc (package): 46163-209-95
ndc (package): 46163-212-95
ndc (package): 46163-206-94
ndc (package): 46163-206-92
ndc (package): 46163-209-92
ndc (package): 46163-212-94
ndc (package): 46163-206-95
ndc (package): 46163-212-92
ndc (product): 46163-209
ndc (product): 46163-206
ndc (product): 46163-212
ndc11 (package): 46163020994
ndc11 (package): 46163020694
ndc11 (package): 46163021292
ndc11 (package): 46163020995
ndc11 (package): 46163021294
ndc11 (package): 46163020695
ndc11 (package): 46163020992
ndc11 (package): 46163021295
ndc11 (package): 46163020692
spl id: 579dba0f-f820-8f9a-e063-6294a90a76b0
spl set id: a98facd6-9daa-4d37-8209-63a0599dbfaa

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.